As Psychedelic Use Grows, Therapists Are Learning to Adapt

In quiet ways, psychedelics are re-entering the cultural conversation.

For some people, that conversation begins in research labs or policy debates. For others, it starts much closer to home—in therapy sessions, wellness practices, and personal explorations of consciousness.

As interest in substances like psilocybin, LSD, and MDMA continues to grow, mental health professionals are increasingly encountering a new reality: many clients are already engaging with psychedelics in some form, whether through ceremonial use, personal experimentation, or microdosing practices intended to support emotional wellbeing.

Yet these experiences often remain unspoken.

For many people, discussing psychedelic use with a therapist or physician still carries a sense of uncertainty. Despite the growing scientific research around psychedelics, these substances remain federally scheduled in the United States, and the cultural stigma surrounding them hasn’t fully disappeared. As a result, some individuals choose to process their experiences privately rather than bring them into clinical conversations where support might be available.

A Cultural Shift in Motion

Recent research suggests that psychedelic use in the United States is no longer a fringe phenomenon.

A January 2026 report from the RAND Corporation, based on a nationally representative survey of more than 10,000 adults, estimated that around 11 million Americans used psilocybin in the past year alone, making it the most commonly used psychedelic substance in the country.

The study also highlighted the growing practice of microdosing, in which people take very small amounts of psychedelics to explore potential effects on mood, focus, or creativity. Across psilocybin, LSD, and MDMA, roughly 10 million Americans reported microdosing within the same period.

Public attitudes are shifting alongside these trends. According to a February 2026 RAND survey, nearly one in four Americans now supports legal access to psilocybin, a level of public support researchers say is comparable to where cannabis stood before the first wave of medical marijuana laws in the 1990s.

Reflecting that change, at least 18 U.S. states are currently exploring psychedelic legislation, and several ballot initiatives may appear in upcoming elections.

The Psychedelic Conversation Is Already Happening

For clinicians who still see psychedelic therapy as something far in the future, one word often reframes the conversation: ketamine.

Ketamine-assisted therapy has already become a part of contemporary mental health care. Originally developed as an anesthetic, ketamine is now prescribed off-label in many clinical settings for treatment-resistant depression and other mental health conditions. Specialized ketamine clinics operate across the United States, and the FDA-approved medication Spravato has further expanded access.

In many cases, therapists are already working with clients who are undergoing ketamine treatments or experimenting with microdosing on their own. These experiences may influence therapy in subtle ways, shaping emotional insights, personal reflections, or shifts in perspective.

Understanding how to support these conversations is becoming an increasingly valuable skill.

What Psychedelic Literacy Really Means

When people hear the phrase “psychedelic therapy,” they often imagine therapists guiding psychedelic sessions directly.

In practice, however, many clinicians contribute to this field in a much simpler way: by helping clients process and integrate their experiences afterward.

This emerging area of expertise is often described as psychedelic literacy—an understanding of the psychological dynamics surrounding psychedelic experiences and the ability to support clients who are exploring them.

For therapists and wellness practitioners, psychedelic literacy can include:

  • Creating a safe space for clients to discuss psychedelic experiences
  • Supporting the integration process after a psychedelic journey
  • Understanding potential risks or contraindications
  • Providing harm-reduction education
  • Offering nonjudgmental support when clients disclose use
  • Knowing when referral to specialized practitioners may be appropriate

Importantly, developing this literacy does not require clinicians to administer psychedelic substances themselves. Instead, it allows them to engage thoughtfully with experiences that clients may already be bringing into therapy.

Integration: The Work That Follows the Experience

In many ways, the psychedelic experience itself is only the beginning.

Researchers and practitioners often emphasize the importance of integration, the therapeutic process that unfolds after a psychedelic journey. During this period, individuals reflect on the insights or emotional material that emerged during the experience and explore how those insights may translate into everyday life.

Sometimes this process unfolds gradually. Feelings or realizations that surfaced during a psychedelic experience may continue to evolve weeks or even months later. Changes in identity, values, or relationships can follow, and these shifts may feel both exciting and disorienting.

With thoughtful support, integration can help individuals transform fleeting insights into meaningful, lasting change.

Occasionally, psychedelic experiences can open the door to deeply intense psychological states—what some researchers refer to as spiritual emergence or spiritual emergency.

These moments can involve powerful shifts in perception, identity, or emotional awareness. While they may resemble psychological crises on the surface, they can also represent profound moments of transformation when approached with care and support.

For clinicians who understand these dynamics, the goal is not necessarily to interpret every unusual experience as pathology, but to provide grounded guidance that helps individuals move through the process safely and constructively.

Meeting a Changing Landscape

With millions of Americans already engaging with psychedelics in some form, the therapeutic landscape is gradually evolving.

Ketamine clinics now operate in major cities. Psychedelic research continues to expand in universities and medical centers. Legislative discussions are unfolding across multiple states.

At the same time, many people are quietly exploring these substances in personal ways—often with the hope of improving their mental health, understanding themselves more deeply, or reconnecting with meaning in their lives.

For therapists and clinicians, developing an informed perspective on psychedelics may simply be part of keeping pace with the world their clients are living in.

As this cultural shift continues to unfold, psychedelic literacy may become less about entering a new field—and more about understanding an experience that is already part of many people’s lives.